Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11191734 Ketamine transdermal delivery system

Patent 11191734 was granted and assigned to Shenox Pharmaceuticals on December, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Shenox Pharmaceuticals

0

Current Assignee

Shenox Pharmaceuticals

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Huadong Tang0

Hock S. Tan0

Michael Mayersohn0

Date of Patent

December 7, 2021

0

Patent Application Number

157361820

Date Filed

June 27, 2016

0

Patent Citations Received

US Patent 11559497 Transdermal drug delivery system for ketamine

US Patent 11980595 Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases

0

US Patent 11426367 Methods of treating substance abuse

US Patent 11707440 Esketamine for the treatment of depression

0

Patent Primary Examiner

Jessica Worsham

0

Patent abstract

The present invention is directed to a transdermal delivery device comprising ketamine and formulations thereof. The present invention is also directed to a transdermal delivery device comprising ketamine for the treatment of major depressive disorder (MDD) and/or pain. The present invention is further directed to a transdermal delivery device comprising ketamine and abuse deterrent agents.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11191734 Ketamine transdermal delivery system

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool